Okla. Stat. tit. 63, § 63-2-303

A. The Director of the Oklahoma State Bureau of Narcotics and

Dangerous Drugs Control shall register an applicant to own a medical

facility as described in subsection C of Section 2-302 of this

title, or to manufacture, distribute, dispense, prescribe,

administer or use for scientific purposes controlled dangerous

substances included in Schedules I through V of Section 2-101 et

seq. of this title unless the Director determines that the issuance

of such registration is inconsistent with the public interest. In

determining the public interest, the following factors shall be

considered:

Oklahoma Statutes - Title 63. Public Health and Safety Page 937

1. Maintenance of effective controls against diversion of

particular controlled dangerous substances and any Schedule I or II

substance compounded therefrom into other than legitimate medical,

scientific or industrial channels including examination of the

fitness of his or her employees or agents to handle dangerous

substances;

2. Compliance with applicable state and local law;

3. Has been found guilty of, entered a plea of guilty or nolo

contendere to a charge under the Uniform Controlled Dangerous

Substances Act or any other state or federal law relating to any

substance defined herein as a controlled dangerous substance or any

felony under the laws of any state or the United States;

4. Furnishing by the applicant false or fraudulent material

information in any application filed under Section 2-101 et seq. of

this title;

5. Past experience in the manufacture, distribution,

dispensing, prescribing, administering or use for scientific

purposes of controlled dangerous substances, and the existence in

the establishment of effective controls against diversion;

6. Denial, suspension or revocation of the applicant’s federal

registration to manufacture, distribute or dispense controlled

dangerous substances as authorized by federal law; and

7. Such other factors as may be relevant to and consistent with

the public health and safety.

Nothing herein shall be deemed to require individual licensed

pharmacists to register under the provisions of the Uniform

Controlled Dangerous Substances Act.

B. Registration granted under subsection A of this section

shall not entitle a registrant to manufacture, distribute, dispense,

prescribe, administer or use for scientific purposes controlled

dangerous substances in Schedule I or II other than those specified

in the registration.

C. Practitioners shall be registered to dispense, prescribe,

administer or use for scientific purposes substances in Schedules II

through V if they are authorized to carry on their respective

activities under the laws of this state. A registration application

by a practitioner who wishes to conduct research with Schedule I

substances shall be accompanied by evidence of the applicant’s

federal registration to conduct such activity and shall be referred

to the Medical Research Commission for advice. The Medical Research

Commission shall promptly advise the Director concerning the

qualifications of each practitioner requesting such registration.

Registration for the purpose of bona fide research or of use for

scientific purposes with Schedule I substances by a practitioner

deemed qualified by the Medical Research Commission may be denied

only on a ground specified in subsection A of Section 2-304 of this

title or if there are reasonable grounds to believe that the

Oklahoma Statutes - Title 63. Public Health and Safety Page 938

applicant will abuse or unlawfully transfer such substances or fail

to safeguard adequately such applicant’s supply of such substances

against diversion from legitimate medical or scientific use.

D. Fees for registration under this section shall be as

follows:

Practitioners and mid-level

practitioners $140.00 per year

of registration

Home Care Agencies, Hospices &

Home Care Services $140.00 annually

Medical Facility Owners $300.00 annually
tances or fail

to safeguard adequately such applicant’s supply of such substances

against diversion from legitimate medical or scientific use.

D. Fees for registration under this section shall be as

follows:

Practitioners and mid-level

practitioners $140.00 per year

of registration

Home Care Agencies, Hospices &

Home Care Services $140.00 annually

Medical Facility Owners $300.00 annually

Distributors $300.00 annually

Manufacturers $2,500.00 annually

Manufacturer, Wholesaler, or

Distributor of drug products

containing pseudoephedrine

or phenylpropanolamine $300.00 annually

E. Compliance by manufacturers and distributors with the

provisions of the federal Controlled Substances Act, 21 U.S.C.,

Section 801 et seq., respecting registration, excluding fees, shall

be deemed sufficient to qualify for registration under Section 2-101

et seq. of this title.

F. Applications for renewal of registration shall open on the

first day of July annually. Applications for renewal shall be

considered timely if submitted by the first day of September

annually. Registrations not renewed by the final day of any

calendar year in which the registration was issued shall be

ineligible for renewal and shall require a new registration upon

return to the Bureau. With notice provided prior to expiration, the

Director may waive the requirement of a new registration pursuant to

promulgated rules. New applications with substantive changes to the

original registration shall not be considered a transfer of any

activity of a continuing nature.